This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.94% per year. These returns cover a period from January 1, 1988 through July 6, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Honeywell (HON) Chosen by KIPIC for PRIZe Project in Kuwait
by Zacks Equity Research
KIPIC will use Honeywell's (HON) front-end engineering design and advanced process control technology for PRIZe project.
Macquarie's (MIC) Q3 Earnings Rise Y/Y, Revenues Decline
by Zacks Equity Research
Macquarie's (MIC) third-quarter revenues decline year over year on account of lacklustre performance across its segments.
Macquarie (MIC) Q3 Earnings Match Estimates
by Zacks Equity Research
Macquarie (MIC) delivered earnings and revenue surprises of 0.00% and -2.97%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
Can Issues in Power Ail General Electric's (GE) Q3 Earnings?
by Zacks Equity Research
General Electric's (GE) Power segment's third-quarter results are expected to reflect adverse impacts of prevailing internal and external challenges. Restructuring efforts might have provided relief.
Can Aviation and Renewable Energy Aid GE in Q3 Earnings?
by Zacks Equity Research
General Electric's (GE) Aviation segment's third-quarter results are expected to reflect gains from solid LEAP engine demand. Renewable Energy is anticipated to have benefited from onshore business.
Macquarie (MIC) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Macquarie (MIC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Carlisle (CSL) Q3 Earnings Surpass Estimates, Revenues Miss
by Zacks Equity Research
Carlisle's (CSL) third-quarter 2019 results reflect benefits from organic sales growth, acquired assets and margin improvement.
United Technologies (UTX) Q3 Earnings & Revenues Top, Up Y/Y
by Zacks Equity Research
United Technologies' (UTX) third-quarter earnings jump year over year on the back of solid performance across most of its segments.
United Technologies' & Raytheon's Shareholders Approve Merger
by Zacks Equity Research
United Technologies' (UTX) merger with Raytheon is likely to generate in excess of $1 billion in gross annual run-rate cost synergies by the fourth year of completion of the deal.
3M Closes Acelity Buyout, Boosts Medical Solutions Business
by Zacks Equity Research
3M's (MMM) Acelity buyout will likely be beneficial for the medical solutions business under the Health Care segment.